Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
11 - 20 of 22
- Direct detection and identification of neuro-oncology markers in brain tumoursFrom1 Oct 2019 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- SAFE ADVISOR : Selection and Assignment For an Exploratory, Adjustible Vaccine through Immune Stratification for brain cancer.From1 Oct 2019 → 30 Sep 2023Funding: Foundations, funds and other with scientific goal
- FDA approved NP cellular hitchhiking system for targeted combination therapy and diagnosis in glioblastomaFrom2 May 2019 → 2 May 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysisFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
- Determination of genetic and therapeutic dependencies of patient-derived models of brain cancerFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
- The role of galectin-1 in macrophage accumulation, phenotype and function in high-grade gliomas.From1 Oct 2014 → 17 Jul 2015Funding: FWO fellowships
- Local and systemic immune interactions in malignant gliomasFrom1 Aug 2013 → 19 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluation of galectin-1 targeting drugs in combination with chemo-immunotherapy in the treatment of high-grade glioma.From1 Aug 2012 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
- Multimodal image-guided transcranial magnetic stimulation in the delineation of eloquent cerebral cortex in the neurosurgical patient and the treatment of refractory focal epilepsyFrom1 Aug 2012 → 11 Jun 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- "BD FACS Verse" Flow Cytometer.From16 Apr 2012 → 25 Oct 2018Funding: Hercules - Small and Medium size research infrastructure
Publications
1 - 10 of 141
- MALDI-MSI-LC-MS/MS Workflow for Single-Section Single Step Combined Proteomics and Quantitative Lipidomics(2024)
Authors: Steven De Vleeschouwer
- Leukocyte- and platelet-rich fibrin in cranial surgery: a single-blinded, prospective, randomized controlled noninferiority trial.(2024)
Authors: Birgit Coucke, Steven De Vleeschouwer, Laura Van Gerven, Tom Theys
Pages: 1 - 9 - Lymph node and tumor-associated PD-L1+macrophages antagonize dendritic cell vaccines by suppressing CD8+T cells(2024)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Sabine Tejpar, Steven De Vleeschouwer, Abhishek Garg
- Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era(2024)
Authors: Steven De Vleeschouwer
Pages: 191 - 202 - Impact of the COVID-19 Pandemic on Incidence and Observed Survival of Malignant Brain Tumors in Belgium(2024)
Authors: Steven De Vleeschouwer
- Germline heterozygous deletion containing CDKN2A/CDKN2B as genetic substrate for rare familial neural and skin tumor syndrome(2024)
Authors: Hilde Brems, Paul Clement, Steven De Vleeschouwer, Frank Van Calenbergh, Eric Legius
Pages: 583 - 583 - Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- Cancer registration, molecular marker status and adherence to the WHO 2016 classification of pathology reports for glioma diagnosed during 2017-2019 in Belgium(2023)
Authors: Steven De Vleeschouwer
Pages: 365 - 376 - Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma(2023)
Authors: Lise Finotto, Basiel Cole, Maxime Vanmechelen, Bram Boeckx, Diether Lambrechts, Ludo Van Den Bosch, Steven De Vleeschouwer, Frederik De Smet
- ONCO-FUNCTIONAL OUTCOME AFTER RESECTION FOR ELOQUENT GLIOBLASTOMA (GLIOFO STUDY): A PROPENSITY-SCORED ANALYSIS OF AN INTERNATIONAL, MULTICENTER COHORT STUDY(2023)
Authors: Lien Solie, Steven De Vleeschouwer
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)